After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
The medical device company has two pending acquisitions worth just under $40 billion combined.
The company reported flat but in line earnings of $1.06 per share.
St. Jude Medical (STJ) stock is declining Tuesday afternoon ahead of the medical device company’s 2016 second quarter earnings due out before tomorrow’s opening bell.
Wedbush analyst Tao Levy also does not expect to see rival offers to emerge for St. Jude Medical.
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.